A peptide sequence from mouse tissue factor inhibits human tissue factor dependent factor X activation.
Synthetic peptides based on the putative factor X recognition site of human (Thr-Leu-Tyr-Tyr-Trp-Lys-Ser-Ser-Ser-Ser), rabbit (Thr-Leu-Tyr-Tyr-Trp-Arg-Ala-Ser-Ser-Thr), and murine tissue factor (Ile-Ile-Thr-Tyr-Arg-Lys-Gly-Ser-Ser-Thr) were dose-dependent inhibitors of human tissue factor/factor VIIa catalyzed factor X activation with IC50 values of 220, 17, and 33 microM, respectively. The mouse results were highly surprising given the low homology between the human and mouse sequence (40%) and that mouse tissue factor, in contrast with rabbit tissue factor, does not support the procoagulant activity of human factor VIIa on factor X. The inhibitory mechanism of the murine peptide was noncompetitive with respect to factor X but competitive with respect to tissue factor, indicating the peptide competes with tissue factor (or the tissue factor/factor VIIa complex) for binding to factor X. The peptide could be N-terminally truncated by two Ile without loss of inhibitory activity or changed inhibitory mechanism. Substitution of two Gly for the two Ile, which increased solubility, decreased IC50 to 17 microM whereas scrambling the peptide made it inactive.
Orning
L
L
Nycomed Imaging AS, Oslo, Norway. lars.oerning@axisbio.no
Arbo
B E
BE
Fischer
P M
PM
Sakariassen
K S
KS
D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites; D002384:Catalysis; D015942:Factor VIIa / Q000378:metabolism; D005170:Factor X / Q000187:drug effects / Q000378:metabolism*; D015951:Factor Xa / Q000378:metabolism; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000138:chemical synthesis* / Q000494:pharmacology; D011817:Rabbits; D016415:Sequence Alignment; D013925:Thromboplastin / Q000737:chemistry*
D010446:Peptide Fragments; D005170:Factor X; D013925:Thromboplastin; D015942:Factor VIIa; D015951:Factor Xa